Cephalon, Inc. v. Watson Pharmaceuticals, Inc.
Opinion
NOTE: This order is nonprecedential
United States Court of Appeals for the Federal Circuit
CEPHALON, INC. AND CIMA LABS, INC., Plaintiffs-Appellants,
V.
WATSON PHARMACEUTICALS, INC., WATSON LABORATORIES, INC., AND WATSON PHARMA, INC., Defendants-Appellees.
2011-1325
Appeal from the United States District Court for the
District of Delaware in case no. 08-CV-0330, Judge Sue L. Robinson.
ON MOTION
O R D E R Cephalon, Inc. and CIMA Labs, Inc., move for a 30-
day extension of time, until August 6, 2012, to file their reply brief due to settlement negotiations.
Upon consideration thereof,
IT IS ORDERED THAT:
CEPHALON V. WATSON PHARMA
The motion is granted.
JUL 1 3 2012
Date
ccc William F. Lee, Esq.
J ames K. Stronski, Esq.
FoR THE CoURT
/s/ Jan Horbal Jan Horbaly Clerk
ga F°“
nmsensnn.ic:acurr JUL 1 3 ZU"|Z JANHURBALY CLEBK
Free access — add to your briefcase to read the full text and ask questions with AI
Cephalon, Inc. v. Watson Pharmaceuticals, Inc. (Cephalon, Inc. v. Watson Pharmaceuticals, Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.